home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Biomarkers UK: In-Person

 
  March 09, 2022  
     
 
Oxford Global, London, UK
03 - 04 May 2022


https://www.oxfordglobal.co.uk/biomarkers-series-uk/agenda/download-agenda/
 
 
Organized by: OxfordGlobal
Invited Speakers: Adam Platt Astrazeneca, Jarema Kochan Turnstone Biologics, Alastair Brown Heptares, Andrea Renninger BMS, David Krige PsiOxus, Clare Jones Talisman Therapeutics, JEANNETTE FUCHS Associate Scientist, Personalized Medicine, Debiopharm ADEELA KAMAL Senior Vice President, Biology & Translational Medicine, SpringWorks Therapeutics ELTON REXHEPAJ Data Scientist – Artificial Intelligence and Deep Analytics R&D, Sanofi ELIZABETH HARRINGTON Executive Director, Translational Medicine, AstraZeneca CHRISTOPHER PETERS Clinical Senior Lecturer, Imperial College London PIA DAVIDSSON Associate Director, Translational Science, AstraZeneca LAURA KNIGHT Vice President of Data Sciences, Almac Diagnostic Services ISABELLA GASHAW Principal Clinical Biomarker Lead, Cardiometabolism, Boehringer Ingelheim VINCENT MIKOL Head of Translational Sciences, Sanofi MADS ROPKE Senior Principal Scientific Advisor, Clinical Pharmacology, LEO Pharma A/S SARAH BIRCH Programme Manager, Cancer Research UK CLARE BALENDRAN Vice President, Head of Translational Medicine, Novo Nordisk LOUISE MAYMANN NITZE Principal Translational Medicine Scientist, Novo Nordisk SVETLANA MUKHINA, CDx Global Regulatory Lead, Associate Director Global Regulatory APARNA RAVAL Director, Clinical Biomarkers; Translational Science Department, Arcus Biosciences DMITRY KAMINSKIY Managing Partner & Co-Founder, Deep Knowledge Group SHONIT PUNWANI Professor of Magnetic Resonance and Cancer Imaging, UCL CAROLINE MOORE Professor of Urology, UCL GERT ATTARD Endowed Chair in Urological Cancer, UCL MARK EMBERTON Professor of Interventional Oncology, UCL JENNIFER BARNETT Chief Executive Officer, Monument Therapeutics RICHARDUS VONK Vice President, Head of Oncology Statistics and Data Management, Bayer Pharma AG PHILIP BEER Vice President, Head of Research and Translational Medicine, Step Pharma GERGELY TOTH Chief Executive Officer & Chief Scientific Officer, Cantabio STEPHANIE TRAUB Associate Director, UCB TOBIN J. CAMMETT Director - Biomarker Development, Alexion Pharmaceuticals, Inc VALERIE TALY Research Director, INSERM ANGELA YIU Bioinformatician, Pathios Therapeutics GRAHAM BALL Professor, Nottingham Trent University, GAYLE MARSHALL Head of Biomarkers, Medicines Discovery Catapult
 
Deadline for Abstracts: N/A
 
Registration: https://www.oxfordglobal.co.uk/biomarkers-series-uk/book-now/
E-mail: b.westmore@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.